Name: Biological Response Modifiers in Human Oncology and Immunology (en Inglés)
SKU: 58660077
Price: 95.40 USD
Availability: InStock
Author: Szentivanyi, Andor

portada Biological Response Modifiers in Human Oncology and Immunology (en Inglés)

Biological Response Modifiers in Human Oncology and Immunology (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Szentivanyi, Andor

Idioma

Inglés

N° páginas

320

Encuadernación

Tapa Blanda

Dimensiones

25.4x17.8x1.8 cm

Peso

0.59 kg.

ISBN13

9781475714128

Categorías

Oncología
Inmunología

Biological Response Modifiers in Human Oncology and Immunology (en Inglés)

Szentivanyi, Andor (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 24 días háb.

$ 190.80$ 95.40

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 95.40

Llega entre el 22 Sep y el 05 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Biological Response Modifiers in Human Oncology and Immunology (en Inglés)"

The topic of biological response modifiers has attracted the attention of many biomedical investigators, including immunologists, oncologists, pharmacologists, microbiologists, and biochemists, as well as clinical practitioners of medicine. This has occurred mainly because of the realization that the complex system of cellular and humoral interactions culminating in a productive immune response is under exquisite regulatory control for normal immune responses and that loss of control may markedly influence the capability of a host to respond in a productive manner to the numerous immunologic "insults" encountered in the environment. Furthermore, biological response modification is considered by many to be a natural offshoot of the relatively new application of "immunotherapy" to cancer. It is widely recognized that "immunotherapy" was practiced at the end of the last century and the beginning of this century when it was recognized that microbial infections were caused by distinct species of bacteria and that passive administration of serum con- taining antibody to these microbes or their products could, in many cases, favorably influence the outcome of an infectious process.